| Literature DB >> 26779503 |
Hala Mahfouz Badran, Waleed Abdou Ibrahim1, Naglaa Faheem2, Rehab Yassin1, Tamer Alashkar1, Magdi Yacoub.
Abstract
BACKGROUND: Left ventricular outflow tract obstruction (LVOT) is an independent predictor of adverse outcome in hypertrophic cardiomyopathy (HCM). It is of major importance that the provocation modalities used are validated against each other. AIM: To define the magnitude of LVOT gradients provocation during both isosorbide dinitrate (ISDN) inhalation and treadmill exercise in non-obstructive HCM and analyze the correlation to the electromechanical delay using speckle tracking.Entities:
Keywords: LVOT obstruction provocation; electromechanical delay; hypertrophic cardiomyopathy
Year: 2015 PMID: 26779503 PMCID: PMC4448073 DOI: 10.5339/gcsp.2015.15
Source DB: PubMed Journal: Glob Cardiol Sci Pract ISSN: 2305-7823
Figure 1.LV longitudinal strain curves in apical 3Ch of HCM patient: (A) Latent obstruction: electromechanical delay (TPP) between basal and mid segments is 60 ms in (B) Non obstructive: the difference between TTP of mid and basal septal segments is 0 ms.
Hemodynamics during ISDN inhalation.
| LVOTO (mmHg) | HR (b/min) | SBP (mmHg) | DBP (mmHg) | |
| Rest | 12.7 ± 9.7 | 75 ± 17 | 120 ± 20 | 79 ± 14 |
| Min 2 | 17 ± 16 | 80 ± 14 | 114 ± 18 | 75 ± 12 |
| Min 5 | 25.8 ± 27* | 85 ± 16* | 106 ± 19* | 74 ± 14 |
| Min 10 | 18 ± 18 | 77 ± 14 | 112 ± 19 | 77 ± 12 |
* : p < 0.01 versus rest value. LVOTO: gradient across left ventricular outflow tract; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure.
Clinical and conventional echocardiographic data.
| All HCM cohort | Latent obstruction | Non-obstruction | p-value | |
| Age (year) | 38 ± 13 | 39 ± 14 | 37 ± 13 | 0.9 |
| Male | 25 (64%) | 8 (57%) | 17 (66%) | 0.5 |
| Familial HCM | 16 (41%) | 5 (36%) | 11 (44%) | >0.05 |
| NYHA I | 9 (23.1%) | 4 (29%) | 5 (20%) | 0.05 |
| NYHA II | 22 (56.4%) | 7 (50%) | 15 (60) | >0.05 |
| NYHA III/IV | 8 (20.5%) | 3 (21%) | 5 (20%) | >0.05 |
| AF | 4 (10.2%) | 0 (0%) | 4 (16%) | >0.05 |
| Asymmetric LVH | 32 (82%) | 12 (86%) | 20 (80%) | >0.05 |
| Concentric LVH | 7 (18%) | 2 (14%) | 5 (20%) | >0.05 |
| No/Mild MR | 26 (66.7%) | 7 (50%) | 19 (76%) | 0.07 |
| Moderate MR | 9 (23.1) | 3 (21%) | 6 (24%) | 0.09 |
| Severe MR | 4 (10.2%) | 4 (29%) | 0 (0%) | 0.03 |
| SAM | 11 (28.2%) | 9 (64%) | 2 (8%) | 0.0001 |
| LA (mm) | 39.8 ± 7.6 | 40 ± 8.3 | 36 ± 3.4 | 0.8 |
| LAV (ml) | 72.4 ± 30 | 83 ± 83 | 64 ± 24 | 0.2 |
| ESD (mm) | 22.1 ± 5 | 21.4 ± 5.2 | 22.4 ± 5.2 | 0.2 |
| EDD (mm) | 36.4 ± 6 | 37.7 ± 6.6 | 35.5 ± 5.7 | 0.5 |
| EF (%) | 70.5 ± 7 | 75 ± 11 | 67 ± 10 | 0.03 |
| SPT (mm) | 26.4 ± 5.5 | 26 ± 7 | 27 ± 5 | 0.6 |
| LVPW (mm) | 15.4 ± 4 | 15.4 ± 3 | 15.3 ± 2.7 | 0.9 |
| LVMI (gm/m2) | 224 ± 64 | 237 ± 67 | 218 ± 65 | 0.3 |
| LVOTG (mmHg) | 12.7 ± 9.7 | 69 ± 18 | 11.5 ± 7 | 0.001 |
| E/A | 1.25 ± 0.55 | 0.9 ± 0.26 | 1.4 ± 0.58 | 0.01 |
| PAP (mmHg) | 26 ± 8 | 24 ± 5 | 26 ± 9 | 0.5 |
NYHA: New York Heart Association; AF: atrial fibrillation; LVH: left ventricular hypertrophy, MR: mitral regurgitation; SAM:systolic anterior motion; LA left atrium; ESD: left ventricular end-systolic diameter, EDD: left ventricular end-diastolic diameter; EF: ejection fraction, MWT:maximal wall thickness, LVPW = posterior wall thickness, SPT: septal thickness; LVMI:left ventricular mass index, LVOTG left ventricular outflow tract gradient, DT: E/A: ratio of early to late diastolic mitral inflow velocity, PAP:pulmonary artery pressure.
LV longitudinal strain and regional electromechanical delay.
| Latent obstruction | Non-obstruction | p-value | |
| εsys septum (%) | − 12.2 ± 10.6 | − 10.6 ± 7.7 | 0.7 |
| εsys lateral (%) | − 14.2 ± 8.3 | − 11.2 ± 6.4 | 0.4 |
| εsys anterior (%) | − 11.8 ± 7 | − 9.5 ± 5.7 | 0.7 |
| εsys inferior (%) | − 9.9 ± 4.9 | − 9.6 ± 5 | 0.7 |
|
|
|
|
|
| TTP basal AS | 382 ± 78 | 339 ± 83 | 0.66 |
| TTP mid AS | 413 ± 90 | 333 ± 95 | 0.001 |
| TTP apical AS | 367 ± 124 | 314 ± 77 | 0.2 |
|
|
|
|
|
| TTP basal lateral | 451 ± 116 | 389 ± 88 | 0.01 |
| TTP mid lateral | 440 ± 121 | 373 ± 77 | 0.01 |
| TTP apical lateral | 385 ± 161 | 330 ± 111 | 0.06 |
|
|
|
|
|
| TTP basal anterior | 453 ± 158 | 339 ± 126 | 0.002 |
| TTP mid anterior | 431 ± 168 | 329 ± 114 | 0.002 |
| TTP apical anterior | 400 ± 118 | 323 ± 109 | 0.1 |
|
|
|
|
|
| TTP basal inferior | 398 ± 135 | 363 ± 114 | 0.4 |
| TTP mid inferior | 403 ± 130 | 357 ± 88 | 0.26 |
| TTP apical inferior | 393 ± 131 | 314 ± 95 | 0.07 |
|
|
|
|
|
| TTP basal PS | 363 ± 35 | 336 ± 30 | 0.5 |
| TTP mid PS | 385 ± 27 | 359 ± 27 | 0.78 |
|
|
|
|
|
εsys: peak systolic strain; TTP: time to peak strain; AS: antero-septal; PS: postero-septal.
Relation of left ventricular outflow gradient to regional electromechanical delay.
|
|
|
|
|
|
|
|
|
|
| EE | R = 0.082 | r = 0.43 | r = 0.28 | r = 0.42 | r = 0.41 | r = 0.204 | r = 0.371 | r = 0.244 |
| P = 0.63 | p = 0.008 | p = 0.084 | p = 0.009 | p = 0.011 | p = 0.220 | p = 0.020 | p = 0.135 | |
| ISDN | R = 0.07 | r = 0.45 | r = 0.38 | r = 0.49 | r = 0.49 | r = 0.312 | r = 0.283 | r = 0.190 |
| P = 0.69 | p = 0.005 | p = 0.018 | p = 0.002 | p = 0.002 | p = 0.057 | p = 0.081 | r = 0.25 | |
|
|
|
|
|
|
|
|
| |
| EE | R = 0.36 | r = 0.14 | r = 0.239 | r = 0.279 | r = 0.36 | r = 0.244 | r = 0.052 | |
| P = 0.025 | p = 0.404 | p = 0.142 | p = 0.086 | p = 0.025 | p = 0.135 | p = 0.772 | ||
| ISDN | R = 0.26 | r = 0.143 | r = 0.259 | r = 0.185 | r = 0.223 | r = 0.250 | r = 0.089 | |
| P = 0.109 | p = 0.384 | p = 0.111 | p = 0.259 | p = 0.171 | p = 0.125 | p = 0.569 |
TTP: time to peak strain; EE: exercise echo; ISDN: isosorbide dinitrate; AS: anteroseptal, PS: posteroseptum.; TTP: time to peak strain; SD: standard deviation.
Figure 2.Estimated marginal means of pressure gradient after ISDN: comparison of patients with and without obstruction.
Figure 5.Relationship of PG provocation to difference between basal and mid-septal TTP (r = 0.37, p < 0.02).